Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib

BACKGROUND: Low skeletal muscle mass is significantly associated with severe adverse events (AEs) from chemotherapy, and low tolerability leads to decreased survival. We aimed to investigate whether body skeletal muscle mass is correlated with tolerability and prognosis in patients with hepatocellul...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Liver Cancer
Main Authors: Uojima, Haruki, Chuma, Makoto, Tanaka, Yoshiaki, Hidaka, Hisashi, Nakazawa, Takahide, Iwabuchi, Shogo, Kobayashi, Satoshi, Hattori, Nobuhiro, Ogushi, Katsuaki, Morimoto, Manabu, Kagawa, Tatehiro, Tanaka, Katsuaki, Kako, Makoto, Koizumi, Wasaburo
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2020
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7206580/
https://ncbi.nlm.nih.gov/pubmed/32399433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000504604
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados